Second Hematologic Malignancies Associated With Primary Mediastinal Germ Cell Tumors: A Population-based Study.

Autor: Aguiar-Bujanda D; Department of Medical Oncology, Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Spain., Croissier-Sánchez L, Pérez-Cabrera D, Galván-Ruiz S

Publikováno v: American journal of clinical oncology [Am J Clin Oncol] 2024 Feb 01; Vol. 47 (2), pp. 58-63. Date of Electronic Publication: 2023 Oct 19.

Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Álamo IV registry.

Autor: Martín M; Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense, Madrid, Spain. mmartin@geicam.org.; GEICAM, Spanish Breast Cancer Group, Madrid, Spain. mmartin@geicam.org.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. mmartin@geicam.org., Carrasco E; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Rodríguez-Lescure Á; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital General Universitario de Elche, Elche, Spain., Andrés R; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain., Servitja S; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital del Mar, Barcelona, Spain., Antón A; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain.; Hospital Universitario Miguel Servet, Universidad de Zaragoza, Instituto Investigación Sanitaria Aragón (IISA), Zaragoza, Spain., Ruiz-Borrego M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Virgen del Rocío, Sevilla, Spain., Bermejo B; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain.; Hospital Clínico Universitario de Valencia, Biomedical Research Institute INCLIVA. Universidad de Valencia, Valencia, Spain., Guerrero Á; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Instituto Valenciano de Oncología, Valencia, Spain., Ramos M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro Oncológico de Galicia, A Coruña, Spain., Santaballa A; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario La Fe, Valencia, Spain., Muñoz M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Department of Medical Oncology and Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain., Cruz J; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain., Lopez-Tarruella S; Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense, Madrid, Spain.; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain., Chacón JI; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario de Toledo, Toledo, Spain., Álvarez I; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital de Donostia, San Sebastian, Spain., Martínez P; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Basurto, Bilbao, Spain., Miralles JJ; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Polonio Ó; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Jara C; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Fundación Alcorcón, Alcorcón, Spain., Aguiar-Bujanda D; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Sep; Vol. 201 (2), pp. 151-159. Date of Electronic Publication: 2023 Jun 20.

Primary Breast Lymphoma: Analysis of 55 Cases of the Spanish Lymphoma Oncology Group

Autor: Pérez FF, Lavernia J, Aguiar-Bujanda D, Miramón J, Gumá J, Álvarez R, Gómez-Codina J, Arroyo FG, Llanos M, Marin M, Alfaro J, Quero C, Delgado M, Nogales E, Menarguez F, Martinez N, Torrente M, Royuela A, Abreu D, Provencio M

Publikováno v: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Clinical lymphoma, myeloma & leukemia
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante

We reviewed 55 patients diagnosed with primary breast lymphoma, stages IE and IIE, in 16 Spanish institutions. Of the 55 cases, 96.4% corresponded to non-Hodgkin lymphoma. Results of 5-year progression-free and overall survival were 73% and 76%, resp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::08576e971eace955d9b383feeaf58046
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1595

Combined Oxygen–Ozone and Porcine Injectable Collagen Therapies Boosting Efficacy in Low Back Pain and Disability.

Autor: De Pascalis, Manuela¹ (AUTHOR) manuela.depascalis@asst-fbf-sacco.it, Mulas, Susanna¹ (AUTHOR), Sgarbi, Liliana¹ (AUTHOR) liliana.sgarbi@asst-fbf-sacco.it

Publikováno v: Diagnostics (2075-4418). Nov2024, Vol. 14 Issue 21, p2411. 12p.

Modulation by Ozone Therapy of Oxidative Stress in Chemotherapy-Induced Peripheral Neuropathy: The Background for a Randomized Clinical Trial.

Autor: Clavo B; Research Unit, Hospital Universitario de Gran Canaria Dr. Negrín, 35019 Las Palmas de Gran Canaria, Spain.; Chronic Pain Unit, Dr. Negrín University Hospital, 35019 Las Palmas de Gran Canaria, Spain.; Radiation Oncology Department, Hospital Universitario Dr. Negrín, 35019 Las Palmas de Gran Canaria, Spain.; Universitary Institute for Research in Biomedicine and Health (iUIBS), Molecular and Translational Pharmacology Group, University of Las Palmas de Gran Canaria, 35016 Las Palmas de Gran Canaria, Spain.; Spanish Group of Clinical Research in Radiation Oncology (GICOR), 28290 Madrid, Spain.; Research Network on Health Services in Chronic Diseases (REDISSEC), Instituto de Salud Carlos III, 28029 Madrid, Spain., Martínez-Sánchez G; Scientific Advisor, Freelance, 60126 Ancona, Italy., Rodríguez-Esparragón F; Research Unit, Hospital Universitario de Gran Canaria Dr. Negrín, 35019 Las Palmas de Gran Canaria, Spain., Rodríguez-Abreu D; Medical Oncology Department, Complejo Hospitalario Universitario Insular Materno-Infantil de Gran Canaria, 35016 Las Palmas de Gran Canaria, Spain., Galván S; Medical Oncology Department, Hospital Universitario de Gran Canaria Dr. Negrín, 35019 Las Palmas de Gran Canaria, Spain., Aguiar-Bujanda D; Medical Oncology Department, Hospital Universitario de Gran Canaria Dr. Negrín, 35019 Las Palmas de Gran Canaria, Spain., Díaz-Garrido JA; Psychiatry Department, Hospital Universitario de Gran Canaria Dr. Negrín, 35019 Las Palmas de Gran Canaria, Spain., Cañas S; Psychiatry Department, Complejo Hospitalario Universitario Insular Materno-Infantil de Gran Canaria, 35016 Las Palmas de Gran Canaria, Spain., Torres-Mata LB; Research Unit, Hospital Universitario de Gran Canaria Dr. Negrín, 35019 Las Palmas de Gran Canaria, Spain., Fabelo H; Institute for Applied Microelectronics (IUMA), University of Las Palmas de Gran Canaria (ULPGC), 35017 Las Palmas de Gran Canaria, Spain., Téllez T; Research Network on Health Services in Chronic Diseases (REDISSEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Departamento de Especialidades Quirúrgicas, Bioquímica e Inmunología, Facultad de Medicina, Universidad de Málaga, 29010 Málaga, Spain., Santana-Rodríguez N; Universitary Institute for Research in Biomedicine and Health (iUIBS), Molecular and Translational Pharmacology Group, University of Las Palmas de Gran Canaria, 35016 Las Palmas de Gran Canaria, Spain.; Thoracic Surgery, Department of Surgery, King Faisal Specialist Hospital and Research Center, Riyadh 11564, Saudi Arabia.; College of Medicine, Department of Surgery, Alfaisal University, Riyadh 11533, Saudi Arabia., Fernández-Pérez L; Universitary Institute for Research in Biomedicine and Health (iUIBS), Molecular and Translational Pharmacology Group, University of Las Palmas de Gran Canaria, 35016 Las Palmas de Gran Canaria, Spain., Marrero-Callico G; Institute for Applied Microelectronics (IUMA), University of Las Palmas de Gran Canaria (ULPGC), 35017 Las Palmas de Gran Canaria, Spain.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2021 Mar 10; Vol. 22 (6). Date of Electronic Publication: 2021 Mar 10.